Submit

Login Login

Register Register

Home / Journals / BIOCELL / Online First / doi:10.32604/biocell.2024.050443
Journal Menu
Special lssues
Table of Content

All issues

Online First

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

SAIB Annual Meetings

Open Access

REVIEW

Molecular and cellular mechanisms of neuroprotection by oligopeptides from snake venoms

CARLOS ALBERTO-SILVA*, BRENDA RUFINO DA SILVA
Natural and Humanities Sciences Center, Experimental Morphophysiology Laboratory, Federal University of ABC (UFABC), São Bernardo do Campo, São Paulo, Brazil
* Corresponding Author: CARLOS ALBERTO-SILVA. Email: email
(This article belongs to the Special Issue: Exploring the Cellular Mechanisms of Neurodegenerative Diseases)

BIOCELL https://doi.org/10.32604/biocell.2024.050443

Received 06 February 2024; Accepted 22 March 2024; Published online 06 May 2024

Abstract

Venom snake-derived peptides have multiple biochemical, pharmacological, and toxicological profiles, allowing for the discovery of new medicinal products and therapeutic applications. This review specifically examines the fundamental elements of neuroprotection offered by different oligopeptides derived from snake venom. It also includes a brief evaluation of short peptides that are being considered as potential therapeutic agents. Proline-rich peptides and tryptophyllin family peptides isolated from the crude venom of Viperidae family snakes, specifically Bothrops atrox, Bothrops jararaca, and Bothrops moojeni, have been shown to have pro-survival properties, the ability to reduce oxidative stress, and the ability to promote cell viability and mitochondrial functions. Three significant mechanisms are related to the neuroprotection mediated by snake venom oligopeptides: (1) Activation of the L-arginine metabolite pathway, such as polyamines from ornithine metabolism, which reduces N-methyl-D-aspartate (NMDA)-type glutamate receptor activity; (2) Enhancement of cell viability by activating the nerve growth factor-signaling pathway; and (3) Activation of the Muscarinic acetylcholine receptor subtype M1 (mAChR-M1). These small peptides show promise as neuroprotective agents against a variety of neurodegenerative disorders.

Keywords

Neuroprotective peptides; Neurodegenerative disease; Oxidative stress; Reactive oxygen species; Biopeptides

  • 141

    View

  • 32

    Download

  • 0

    Like

Related articles
Copyright© 2024 Tech Science Press
© 1997-2024 TSP (Henderson, USA) unless otherwise stated

Share Link